Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Or search by our quick links Current share price & latest results Key documents Featured Video: 2025 Preliminary Results Highlights Our Chief Executive Tadeu Marroco shares his views on BATs Preliminary Results for the year ended 31 December 2025
Participation in a community-based diversion program
In reality, of course only time will tell where Campbell's tenure leads the long-beleaguered franchise
J Neurovirol 22:774788 Rahimian P, He JJ (2016b) HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression
Plus, on this list, it is among the most economically friendly
US$ 26.00
US$ 29.42
US$ 26.83
US$ 29.78
US$ 28.31
US$ 20.58
US$ 27.56
US$ 29.61
